Skip Navigation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Harris, S.
Right arrow Articles by Johnson, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harris, S.
Right arrow Articles by Johnson, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 1417-1423, Copyright © 1996 by Oxford University Press


REVIEWS

Myotonic dystrophy: will the real gene please step forward!

S Harris, C Moncrieff and K Johnson
Division of Molecular Genetics, IBLS, University of Glasgow, Anderson College, UK.

The mutation underlying myotonic dystrophy (DM) was identified at the end of 1991 amidst great rejoicing from the patients supporting the research and, not least, from those who spent so long searching for it. Subsequently, the molecular genetic phenomena associated with DM have been clearly explained by the transmission behaviour of the expanding repeat, which remains the only mutation that has been described in patients. We understand the molecular basis of anticipation, why the severe congenital form is almost exclusively transmitted by affected mothers and we have widely accepted models of the population genetics of DM. Yet, despite all these clearly explained molecular events, we appear to be hardly any closer to understanding the molecular pathology of DM than when the mutation was first identified. To understand the reason for this, we have to look in detail at the mutation itself, and in particular at the locus and its complex nuances. In doing so, we begin to realise that DM is unique amongst the Mendelianly inherited disorders, in that the mutation, because of its location in a very gene- rich region of the genome, probably simultaneously renders several genes dysfunctional. The somatic heterogeneity of the repeat, coupled with the involvement of several genes, accounts for the pleiotropy observed in the phenotype. Added to this complexity is the uncertainty of the level at which gene dysfunction or gain of function is occurring. It is possibly at the level of DNA/chromatin structure and/or RNA regulation/processing, and all of these pathways may, in different tissues, contribute to the final phenotype.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
W. J. A. A. van den Broek, M. R. Nelen, D. G. Wansink, M. M. Coerwinkel, H. te Riele, P. J. T. A. Groenen, and B. Wieringa
Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins
Hum. Mol. Genet., January 1, 2002; 11(2): 191 - 198.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Lazarus, J. Varin, Z. Ounnoughene, H. Radvanyi, C. Junien, J. Coste, P. Laforet, B. Eymard, H. M. Becane, S. Weber, et al.
Relationships Among Electrophysiological Findings and Clinical Status, Heart Function, and Extent of DNA Mutation in Myotonic Dystrophy
Circulation, March 2, 1999; 99(8): 1041 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R. L Margolis, O C. Stine, C. M Ward, M. L Franz, A. Rosenblatt, C. Callahan, M. Sherr, C. A Ross, and N. T Potter
Unstable expansion of the CAG trinucleotide repeat in MAB21L1: report of a second pedigree and effect on protein expression
J. Med. Genet., January 1, 1999; 36(1): 62 - 64.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. Buyalos, R. V. Jackson, G. I. Grice, G. I. Hockings, D. J. Torpy, L. M. Fox, L. R. Boots, and R. Azziz
Androgen Response to Hypothalamic-Pituitary-Adrenal Stimulation with Naloxone in Women with Myotonic Muscular Dystrophy
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3219 - 3224.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F L Mastaglia, N Harker, B A Phillips, T J Day, G J Hankey, N G Laing, V Fabian, and B A Kakulas
Dominantly inherited proximal myotonic myopathy and leukoencephalopathy in a family with an incidental CLCN1 mutation
J. Neurol. Neurosurg. Psychiatry, April 1, 1998; 64(4): 543 - 547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Napierala and W. J. Krzyzosiak
CUG Repeats Present in Myotonin Kinase RNA Form Metastable "Slippery" Hairpins
J. Biol. Chem., December 5, 1997; 272(49): 31079 - 31085.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. G. Hamshere, E. E. Newman, M. Alwazzan, B. S. Athwal, and J. D. Brook
Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes
PNAS, July 8, 1997; 94(14): 7394 - 7399.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
C.T. Caskey, M.S. Swanson, and L.T. Timchenko
Myotonic Dystrophy: Discussion of Molecular Mechanism
Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 607 - 614.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.